Skip to main content
. 2024 Feb 16;16(4):808. doi: 10.3390/cancers16040808

Table 1.

Distribution of MDS subtypes in patients suffering from infectious complications according to the WHO 2016 classification, including RAEB-T, on myeloid neoplasms.

MDS Subtype WHO 2016 n %
MDS-SLD 54 3.4
MDS-MLD 446 28.0
MDS-RS-SLD 79 5.0
MDS-RS-MLD 9 0.6
MDS del(5q) 24 1.5
MDS EB 1 212 13.3
MDS EB 2 305 19.1
CMML 1 148 9.3
CMML 2 50 3.1
RAEB-T 220 13.8
MDS/MPN U 14 0.9
RARS-t 22 1.4
unclassifiable 10 0.6
total 1593 100